Eyebright Medical Technology (Beijing) Balance Sheet Health
Financial Health criteria checks 5/6
Eyebright Medical Technology (Beijing) has a total shareholder equity of CN¥2.4B and total debt of CN¥258.8M, which brings its debt-to-equity ratio to 10.6%. Its total assets and total liabilities are CN¥3.0B and CN¥597.9M respectively. Eyebright Medical Technology (Beijing)'s EBIT is CN¥336.7M making its interest coverage ratio -74.8. It has cash and short-term investments of CN¥372.9M.
Key information
10.6%
Debt to equity ratio
CN¥258.79m
Debt
Interest coverage ratio | -74.8x |
Cash | CN¥372.88m |
Equity | CN¥2.44b |
Total liabilities | CN¥597.91m |
Total assets | CN¥3.04b |
Recent financial health updates
Recent updates
Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01Financial Position Analysis
Short Term Liabilities: 688050's short term assets (CN¥938.7M) exceed its short term liabilities (CN¥293.1M).
Long Term Liabilities: 688050's short term assets (CN¥938.7M) exceed its long term liabilities (CN¥304.8M).
Debt to Equity History and Analysis
Debt Level: 688050 has more cash than its total debt.
Reducing Debt: 688050's debt to equity ratio has increased from 0.9% to 10.6% over the past 5 years.
Debt Coverage: 688050's debt is well covered by operating cash flow (92.5%).
Interest Coverage: 688050 earns more interest than it pays, so coverage of interest payments is not a concern.